Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Eur J Haematol. 2024 May;112(5):788-793. doi: 10.1111/ejh.14170. Epub 2024 Feb 4.
Eur J Haematol. 2024.
PMID: 38311570
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
Mayer L, Weskamm LM, Fathi A, Kono M, Heidepriem J, Krähling V, Mellinghoff SC, Ly ML, Friedrich M, Hardtke S, Borregaard S, Hesterkamp T, Loeffler FF, Volz A, Sutter G, Becker S, Dahlke C, Addo MM.
Mayer L, et al. Among authors: weskamm lm.
NPJ Vaccines. 2024 Jan 26;9(1):20. doi: 10.1038/s41541-023-00801-z.
NPJ Vaccines. 2024.
PMID: 38278816
Free PMC article.
Item in Clipboard
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.
Odak I, Riemann L, Sandrock I, Cossmann A, Ramos GM, Hammerschmidt SI, Ritter C, Friedrichsen M, Hassan A, Dopfer-Jablonka A, Stankov MV, Weskamm LM, Addo MM, Ravens I, Willenzon S, Schimrock A, Ristenpart J, Janssen A, Barros-Martins J, Hansen G, Falk C, Behrens GMN, Förster R.
Odak I, et al. Among authors: weskamm lm.
EBioMedicine. 2024 Jan;99:104947. doi: 10.1016/j.ebiom.2023.104947. Epub 2023 Dec 30.
EBioMedicine. 2024.
PMID: 38160529
Free PMC article.
Item in Clipboard
Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens.
Weskamm LM, Dahlke C, Addo MM.
Weskamm LM, et al.
STAR Protoc. 2022 Dec 16;3(4):101902. doi: 10.1016/j.xpro.2022.101902. Epub 2022 Nov 15.
STAR Protoc. 2022.
PMID: 36595922
Free PMC article.
Item in Clipboard
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine.
Weskamm LM, Fathi A, Raadsen MP, Mykytyn AZ, Koch T, Spohn M, Friedrich M; MVA-MERS-S Study Group; Haagmans BL, Becker S, Sutter G, Dahlke C, Addo MM.
Weskamm LM, et al.
Cell Rep Med. 2022 Jul 19;3(7):100685. doi: 10.1016/j.xcrm.2022.100685.
Cell Rep Med. 2022.
PMID: 35858586
Free PMC article.
Item in Clipboard
SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Mellinghoff SC, Mayer L, Robrecht S, Weskamm LM, Dahlke C, Gruell H, Schlotz M, Vanshylla K, Schloser HA, Thelen M, Fink AM, Fischer K, Klein F, Addo MM, Eichhorst B, Hallek M, Langerbeins P.
Mellinghoff SC, et al. Among authors: weskamm lm.
Haematologica. 2022 Oct 1;107(10):2480-2484. doi: 10.3324/haematol.2022.280982.
Haematologica. 2022.
PMID: 35734927
Free PMC article.
No abstract available.
Item in Clipboard
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Mellinghoff SC, Robrecht S, Mayer L, Weskamm LM, Dahlke C, Gruell H, Vanshylla K, Schlösser HA, Thelen M, Fink AM, Fischer K, Klein F, Addo MM, Eichhorst B, Hallek M, Langerbeins P.
Mellinghoff SC, et al. Among authors: weskamm lm.
Leukemia. 2022 Feb;36(2):562-565. doi: 10.1038/s41375-021-01500-1. Epub 2021 Dec 22.
Leukemia. 2022.
PMID: 34937858
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite